---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-361145"
form_type: "8-K"
ticker: "COO"
cik: "0000711404"
company_name: "COOPER COMPANIES, INC."
filed_at: "2021-12-17T23:59:59+00:00"
generated_at: "2026-06-28T00:18:18.713326+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# CooperCompanies completes $1.6B acquisition of Generate Life Sciences, funded by $1.5B term loan

## Summary
- Cooper completed acquisition of Generate Life Sciences for ~$1.605B in cash.
- Generate provides donor egg/sperm, fertility cryopreservation, and newborn stem cell storage.
- Acquisition funded by a $1.5B non-amortizing 5-year senior unsecured term loan.
- Term loan matures Dec 17, 2026; bears interest at LIBOR + 75bps or base rate.
- CooperSurgical adds Generate to strengthen fertility clinic and Ob/Gyn offerings.

## SEC filing metadata
- accession: 0001193125-21-361145
- form_type: 8-K
- ticker: COO
- cik: 0000711404
- company_name: COOPER COMPANIES, INC.
- filed_at: 2021-12-17T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 2.01, 2.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/711404/000119312521361145/0001193125-21-361145-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/711404/000119312521361145/d272863d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-361145
- JSON: https://secwatch.observer/filing/0001193125-21-361145.json
- Plain text: https://secwatch.observer/filing/0001193125-21-361145.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.